FDA Withdraws Draft Guidance on Biosimilar Development

BioSpace (press release) (blog)-44 minutes ago

The U.S. Food and Drug Administration (FDA) withdrew its draft guidance on statistical methods to evaluate the analytical similarity between branded drugs and